- Coronavirus patients do not pose a threat of spreading the disease after 11 days.
- Latest findings may have implications on discharge policy.
- Pre-school staff are among the city-state’s new virus cases.
- Discharged patients outnumber new infections in Singapore for seven straight days.
COVID-19 patients are no longer infectious after 11 days of getting sick even though some may still test positive, according to a new study by infectious disease experts in Singapore, writes Yoolim Lee for Bloomberg.
Not a threat
Coronavirus patients patients do not pose a threat of spreading the disease after 11 days, according to a study.
However, there are chances that some patients may still test COVID-19 positive, reports suggest citing the study by infectious disease experts in Singapore. The study was based on 73 patients in the city-state.
According to the joint research paper by Singapore’s National Centre for Infectious Diseases and the Academy of Medicine, Singapore, a positive test “does not equate to infectiousness or viable virus“. It also said that the virus “could not be isolated or cultured after day 11 of illness.”
The latest findings may have implications on the country’s patient discharge policy. The discharge criteria is currently based on negative test results rather than infectiousness.
Discharged patients outnumber new infections
So far, 13,882, or about 45% of the total 31,068 COVID-19 patients in Singapore have been discharged from hospitals and community facilities. Singapore reported 642 new COVID-19 cases as of noon on Saturday.
- Globally, 5,308,190 people have been infected by coronavirus so far. The total number of deaths from COVID-19 now stands at 340,075.
- The US has the world’s highest number of cases and deaths at 1,622,605 and 97,087, respectively.
- Over 52 lakh people have tested positive worldwide for the novel coronavirus ever since its emergence in China last December.
- More than 3.38 lakh have lost their lives, while over 20 lakh people have recovered worldwide so far.
Did you subscribe to our daily newsletter?
It’s Free! Click here to Subscribe!